Last 12 months
Inside the activity.
0 purchase rows · 33 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 11, 2024 Filed Nov 12, 2024 21:48 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 43,058 | $0.00 Strike: $20.03 | $0.00 |
DisclosureSEC source: 0001127602-24-027044 · form4.xml · derivative · entry 3 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 129,174 Underlying: Ordinary Shares · 43,058 shares Expires 2030-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/14/2023. F4 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 21:48 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
SaleOrdinary Shares | 58,996 | $30.08 | $1,774,576.08 |
DisclosureSEC source: 0001127602-24-027044 · form4.xml · nonDerivative · entry 2 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 83,300 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/14/2023. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.20. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 21:48 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Exercise / conversionOrdinary Shares | 43,058 | $20.03 | $862,451.74 |
DisclosureSEC source: 0001127602-24-027044 · form4.xml · nonDerivative · entry 1 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 142,296 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/14/2023. Read SEC document |
| November 06, 2024 Filed Nov 7, 2024 00:47 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
SaleOrdinary Shares | 10,471 | $29.53 | $309,168.84 |
DisclosureSEC source: 0001127602-24-026629 · form4.xml · nonDerivative · entry 1 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 99,238 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/14/2023. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.50 to $29.61. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request. Read SEC document |
| August 03, 2024 Filed Aug 5, 2024 20:13 UTC |
Gaffin David JosephEVP, CLO, Alkermes, Inc.
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 2,014 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-021587 · form4.xml · derivative · entry 3 Gaffin David Joseph · CIK 0001675905 · EVP, CLO, Alkermes, Inc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,029 Underlying: Ordinary Shares · 2,014 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments commencing on 8/3/2023. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments commencing on 8/3/2023. Read SEC document |
| August 03, 2024 Filed Aug 5, 2024 20:13 UTC |
Gaffin David JosephEVP, CLO, Alkermes, Inc.
|
Tax withholdingOrdinary Shares | 895 | $27.72 | $24,809.40 |
DisclosureSEC source: 0001127602-24-021587 · form4.xml · nonDerivative · entry 2 Gaffin David Joseph · CIK 0001675905 · EVP, CLO, Alkermes, Inc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,901 Read SEC document |
| August 03, 2024 Filed Aug 5, 2024 20:13 UTC |
Gaffin David JosephEVP, CLO, Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 2,014 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-021587 · form4.xml · nonDerivative · entry 1 Gaffin David Joseph · CIK 0001675905 · EVP, CLO, Alkermes, Inc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,796 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| June 29, 2024 Filed Jul 1, 2024 16:51 UTC |
Alva Emily PetersonDirector
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 6,104 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-019581 · form4.xml · derivative · entry 3 Alva Emily Peterson · CIK 0001738422 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,104 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: This award is fully vested in accordance with its terms. F2 · derivative.expiration_date: This award is fully vested in accordance with its terms. Read SEC document |
| June 29, 2024 Filed Jul 1, 2024 16:51 UTC |
Alva Emily PetersonDirector
|
Tax withholdingOrdinary Shares | 1,465 | $24.10 | $35,306.50 |
DisclosureSEC source: 0001127602-24-019581 · form4.xml · nonDerivative · entry 2 Alva Emily Peterson · CIK 0001738422 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,302 Read SEC document |
| June 29, 2024 Filed Jul 1, 2024 16:51 UTC |
Alva Emily PetersonDirector
|
Exercise / conversionOrdinary Shares | 6,104 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-019581 · form4.xml · nonDerivative · entry 1 Alva Emily Peterson · CIK 0001738422 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,767 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| June 29, 2024 Filed Jul 1, 2024 21:02 UTC |
Wilson Frank AndersDirector
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 6,104 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-019607 · form4.xml · derivative · entry 3 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,104 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: This award is fully vested in accordance with its terms. F2 · derivative.expiration_date: This award is fully vested in accordance with its terms. Read SEC document |
| June 29, 2024 Filed Jul 1, 2024 21:02 UTC |
Wilson Frank AndersDirector
|
Tax withholdingOrdinary Shares | 1,465 | $24.10 | $35,306.50 |
DisclosureSEC source: 0001127602-24-019607 · form4.xml · nonDerivative · entry 2 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,995 Read SEC document |
| June 29, 2024 Filed Jul 1, 2024 21:02 UTC |
Wilson Frank AndersDirector
|
Exercise / conversionOrdinary Shares | 6,104 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-019607 · form4.xml · nonDerivative · entry 1 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,460 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| June 29, 2024 Filed Jul 1, 2024 20:58 UTC |
LAURENCIN CATO TDirector
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 6,104 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-019597 · form4.xml · derivative · entry 3 LAURENCIN CATO T · CIK 0001444810 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,104 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: This award is fully vested in accordance with its terms. F2 · derivative.expiration_date: This award is fully vested in accordance with its terms. Read SEC document |
| June 29, 2024 Filed Jul 1, 2024 20:58 UTC |
LAURENCIN CATO TDirector
|
Tax withholdingOrdinary Shares | 1,465 | $24.10 | $35,306.50 |
DisclosureSEC source: 0001127602-24-019597 · form4.xml · nonDerivative · entry 2 LAURENCIN CATO T · CIK 0001444810 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,808 Read SEC document |
| June 29, 2024 Filed Jul 1, 2024 20:58 UTC |
LAURENCIN CATO TDirector
|
Exercise / conversionOrdinary Shares | 6,104 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-019597 · form4.xml · nonDerivative · entry 1 LAURENCIN CATO T · CIK 0001444810 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,273 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| June 29, 2024 Filed Jul 1, 2024 20:59 UTC |
MCKEON BRIAN PDirector
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 6,104 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-019599 · form4.xml · derivative · entry 4 MCKEON BRIAN P · CIK 0001219445 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,104 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F3 · derivative.exercise_date: This award is fully vested in accordance with its terms. F3 · derivative.expiration_date: This award is fully vested in accordance with its terms. Read SEC document |
| June 29, 2024 Filed Jul 1, 2024 20:59 UTC |
MCKEON BRIAN PDirector
|
Tax withholdingOrdinary Shares | 1,465 | $24.10 | $35,306.50 |
DisclosureSEC source: 0001127602-24-019599 · form4.xml · nonDerivative · entry 3 MCKEON BRIAN P · CIK 0001219445 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,780 Read SEC document |
| June 29, 2024 Filed Jul 1, 2024 20:59 UTC |
MCKEON BRIAN PDirector
|
Exercise / conversionOrdinary Shares | 6,104 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-019599 · form4.xml · nonDerivative · entry 2 MCKEON BRIAN P · CIK 0001219445 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,245 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| June 29, 2024 Filed Jul 1, 2024 21:04 UTC |
Wright Christopher IDirector
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 6,104 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-019612 · form4.xml · derivative · entry 3 Wright Christopher I · CIK 0001838503 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,104 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: This award is fully vested in accordance with its terms. F2 · derivative.expiration_date: This award is fully vested in accordance with its terms. Read SEC document |
| June 29, 2024 Filed Jul 1, 2024 21:04 UTC |
Wright Christopher IDirector
|
Tax withholdingOrdinary Shares | 1,465 | $24.10 | $35,306.50 |
DisclosureSEC source: 0001127602-24-019612 · form4.xml · nonDerivative · entry 2 Wright Christopher I · CIK 0001838503 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,416 Read SEC document |
| June 29, 2024 Filed Jul 1, 2024 21:04 UTC |
Wright Christopher IDirector
|
Exercise / conversionOrdinary Shares | 6,104 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-019612 · form4.xml · nonDerivative · entry 1 Wright Christopher I · CIK 0001838503 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,881 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| June 29, 2024 Filed Jul 1, 2024 21:01 UTC |
snyderman nancy lynn MDDirector
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 6,104 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-019603 · form4.xml · derivative · entry 4 snyderman nancy lynn MD · CIK 0001675198 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,104 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F3 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F4 · derivative.exercise_date: This award is fully vested in accordance with its terms. F4 · derivative.expiration_date: This award is fully vested in accordance with its terms. Read SEC document |
| June 29, 2024 Filed Jul 1, 2024 21:01 UTC |
snyderman nancy lynn MDDirector
|
Tax withholdingOrdinary Shares | 1,465 | $24.10 | $35,306.50 |
DisclosureSEC source: 0001127602-24-019603 · form4.xml · nonDerivative · entry 3 snyderman nancy lynn MD · CIK 0001675198 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,639 Read SEC document |
| June 29, 2024 Filed Jul 1, 2024 21:01 UTC |
snyderman nancy lynn MDDirector
|
Exercise / conversionOrdinary Shares | 6,104 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-019603 · form4.xml · nonDerivative · entry 2 snyderman nancy lynn MD · CIK 0001675198 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,104 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| June 29, 2024 Filed Jul 1, 2024 20:55 UTC |
GAYNOR RICHARDDirector
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 6,104 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-019594 · form4.xml · derivative · entry 3 GAYNOR RICHARD · CIK 0001741284 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,104 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: This award is fully vested in accordance with its terms. F2 · derivative.expiration_date: This award is fully vested in accordance with its terms. Read SEC document |
| June 29, 2024 Filed Jul 1, 2024 20:55 UTC |
GAYNOR RICHARDDirector
|
Tax withholdingOrdinary Shares | 1,465 | $24.10 | $35,306.50 |
DisclosureSEC source: 0001127602-24-019594 · form4.xml · nonDerivative · entry 2 GAYNOR RICHARD · CIK 0001741284 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,995 Read SEC document |
| June 29, 2024 Filed Jul 1, 2024 20:55 UTC |
GAYNOR RICHARDDirector
|
Exercise / conversionOrdinary Shares | 6,104 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-019594 · form4.xml · nonDerivative · entry 1 GAYNOR RICHARD · CIK 0001741284 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,460 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| June 29, 2024 Filed Jul 1, 2024 20:54 UTC |
Daglio David Angelo Jr.Director
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 6,104 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-019590 · form4.xml · derivative · entry 4 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,104 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F3 · derivative.exercise_date: This award is fully vested in accordance with its terms. F3 · derivative.expiration_date: This award is fully vested in accordance with its terms. Read SEC document |
| June 29, 2024 Filed Jul 1, 2024 20:54 UTC |
Daglio David Angelo Jr.Director
|
Tax withholdingOrdinary Shares | 1,465 | $24.10 | $35,306.50 |
DisclosureSEC source: 0001127602-24-019590 · form4.xml · nonDerivative · entry 3 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,780 Read SEC document |
| June 29, 2024 Filed Jul 1, 2024 20:54 UTC |
Daglio David Angelo Jr.Director
|
Exercise / conversionOrdinary Shares | 6,104 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-019590 · form4.xml · nonDerivative · entry 2 Daglio David Angelo Jr. · CIK 0001837109 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,245 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| June 29, 2024 Filed Jul 1, 2024 20:52 UTC |
Cooke ShaneDirector
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 6,104 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-019585 · form4.xml · derivative · entry 3 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,104 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: This award is fully vested in accordance with its terms. F2 · derivative.expiration_date: This award is fully vested in accordance with its terms. Read SEC document |
| June 29, 2024 Filed Jul 1, 2024 20:52 UTC |
Cooke ShaneDirector
|
Tax withholdingOrdinary Shares | 3,175 | $24.10 | $76,517.50 |
DisclosureSEC source: 0001127602-24-019585 · form4.xml · nonDerivative · entry 2 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,906 Read SEC document |
| June 29, 2024 Filed Jul 1, 2024 20:52 UTC |
Cooke ShaneDirector
|
Exercise / conversionOrdinary Shares | 6,104 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-019585 · form4.xml · nonDerivative · entry 1 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,081 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| June 09, 2024 Filed Jun 10, 2024 20:56 UTC |
Alva Emily PetersonDirector
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 3,871 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-018322 · form4.xml · derivative · entry 3 Alva Emily Peterson · CIK 0001738422 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,871 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: This award is fully vested in accordance with its terms. F2 · derivative.expiration_date: This award is fully vested in accordance with its terms. Read SEC document |
| June 09, 2024 Filed Jun 10, 2024 20:56 UTC |
Alva Emily PetersonDirector
|
Tax withholdingOrdinary Shares | 930 | $23.91 | $22,236.30 |
DisclosureSEC source: 0001127602-24-018322 · form4.xml · nonDerivative · entry 2 Alva Emily Peterson · CIK 0001738422 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,663 Read SEC document |
| June 09, 2024 Filed Jun 10, 2024 20:56 UTC |
Alva Emily PetersonDirector
|
Exercise / conversionOrdinary Shares | 3,871 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-018322 · form4.xml · nonDerivative · entry 1 Alva Emily Peterson · CIK 0001738422 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,593 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| June 08, 2024 Filed Jun 11, 2024 00:55 UTC |
Wright Christopher IDirector
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 3,301 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-018321 · form4.xml · derivative · entry 3 Wright Christopher I · CIK 0001838503 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,301 Underlying: Ordinary Shares · 3,301 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in three equal annual installments commencing on 6/8/2023. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in three equal annual installments commencing on 6/8/2023. Read SEC document |
| June 08, 2024 Filed Jun 11, 2024 00:55 UTC |
Wright Christopher IDirector
|
Tax withholdingOrdinary Shares | 793 | $23.91 | $18,960.63 |
DisclosureSEC source: 0001127602-24-018321 · form4.xml · nonDerivative · entry 2 Wright Christopher I · CIK 0001838503 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,777 Read SEC document |
| June 08, 2024 Filed Jun 11, 2024 00:55 UTC |
Wright Christopher IDirector
|
Exercise / conversionOrdinary Shares | 3,301 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-018321 · form4.xml · nonDerivative · entry 1 Wright Christopher I · CIK 0001838503 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,570 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:45 UTC |
Alva Emily PetersonDirector
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 17,492 | $0.00 Strike: $23.40 | $0.00 |
DisclosureSEC source: 0001127602-24-017710 · form4.xml · derivative · entry 9 Alva Emily Peterson · CIK 0001738422 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,492 Underlying: Ordinary Shares · 17,492 shares Expires 2034-05-31 F9 · derivative.exercise_date: Shares subject to the stock option award vest and become exercisable in full on 5/31/2025. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:45 UTC |
Alva Emily PetersonDirector
|
GrantRestricted Stock Unit Award · Derivative | 8,013 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017710 · form4.xml · derivative · entry 8 Alva Emily Peterson · CIK 0001738422 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,013 Underlying: Ordinary Shares · 8,013 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F8 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 5/31/2025. F8 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 5/31/2025. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 21:03 UTC |
Wilson Frank AndersDirector
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 17,492 | $0.00 Strike: $23.40 | $0.00 |
DisclosureSEC source: 0001127602-24-017731 · form4.xml · derivative · entry 10 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,492 Underlying: Ordinary Shares · 17,492 shares Expires 2034-05-31 F7 · derivative.exercise_date: Shares subject to the stock option award vest and become exercisable in full on 5/31/2025. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 21:03 UTC |
Wilson Frank AndersDirector
|
GrantRestricted Stock Unit Award · Derivative | 8,013 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017731 · form4.xml · derivative · entry 9 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,013 Underlying: Ordinary Shares · 8,013 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F6 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 5/31/2025. F6 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 5/31/2025. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:56 UTC |
Lurker NancyDirector
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 17,492 | $0.00 Strike: $23.40 | $0.00 |
DisclosureSEC source: 0001127602-24-017727 · form4.xml · derivative · entry 2 Lurker Nancy · CIK 0001450485 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,492 Underlying: Ordinary Shares · 17,492 shares Expires 2034-05-31 F3 · derivative.exercise_date: Shares subject to the stock option award vest and become exercisable in full on 5/31/2025. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:56 UTC |
Lurker NancyDirector
|
GrantRestricted Stock Unit Award · Derivative | 8,013 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017727 · form4.xml · derivative · entry 1 Lurker Nancy · CIK 0001450485 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,013 Underlying: Ordinary Shares · 8,013 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 5/31/2025. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 5/31/2025. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:54 UTC |
LAURENCIN CATO TDirector
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 17,492 | $0.00 Strike: $23.40 | $0.00 |
DisclosureSEC source: 0001127602-24-017726 · form4.xml · derivative · entry 2 LAURENCIN CATO T · CIK 0001444810 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,492 Underlying: Ordinary Shares · 17,492 shares Expires 2034-05-31 F3 · derivative.exercise_date: Shares subject to the stock option award vest and become exercisable in full on 5/31/2025. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:54 UTC |
LAURENCIN CATO TDirector
|
GrantRestricted Stock Unit Award · Derivative | 8,013 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017726 · form4.xml · derivative · entry 1 LAURENCIN CATO T · CIK 0001444810 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,013 Underlying: Ordinary Shares · 8,013 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 5/31/2025. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 5/31/2025. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:58 UTC |
MCKEON BRIAN PDirector
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 17,492 | $0.00 Strike: $23.40 | $0.00 |
DisclosureSEC source: 0001127602-24-017729 · form4.xml · derivative · entry 2 MCKEON BRIAN P · CIK 0001219445 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,492 Underlying: Ordinary Shares · 17,492 shares Expires 2034-05-31 F3 · derivative.exercise_date: Shares subject to the stock option award vest and become exercisable in full on 5/31/2025. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:58 UTC |
MCKEON BRIAN PDirector
|
GrantRestricted Stock Unit Award · Derivative | 8,013 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017729 · form4.xml · derivative · entry 1 MCKEON BRIAN P · CIK 0001219445 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,013 Underlying: Ordinary Shares · 8,013 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 5/31/2025. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 5/31/2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.